USANA Health Sciences Announces Strategic Acquisition of Hiya Health
USANA Health Sciences Announces Strategic Acquisition of Hiya Health
USANA Health Sciences Announces Strategic Acquisition of Hiya Health
USANA 健康科學宣佈戰略收購 Hiya Health
Download as PDFDecember 23, 2024
以 PDF 格式下載 2024 年 12 月 23 日
Hiya is a fast-growing, emerging leader of high-quality children's health & wellness products.
Hiya是高品質兒童健康與保健產品的快速成長的新興領導者。
Broadens USANA's reach into the highly attractive direct-to-consumer channel driven by Hiya's powerful subscription model with runway for sustainable future growth.
在Hiya強大的訂閱模式的推動下,將USANA的影響範圍擴大到極具吸引力的直接面向消費者的渠道,爲未來的可持續增長鋪平了道路。
Expected to be immediately accretive to 2025 adjusted EBITDA.
預計將立即增加到2025年調整後的息稅折舊攤銷前利潤。
9/30/2024 LTM net sales of $103 million, LTM net income of $19 million, and LTM adjusted EBITDA of $22 million.
2024年9月30日LtM淨銷售額爲1.03億美元,LtM淨收入爲1900萬美元,LtM調整後的息稅折舊攤銷前利潤爲2200萬美元。
The Company will discuss the transaction during a conference call on Monday, December 23, 2024, at 5:00 PM ET.
該公司將在美國東部時間2024年12月23日星期一下午5點的電話會議上討論該交易。
SALT LAKE CITY--(BUSINESS WIRE)--USANA Health Sciences, Inc. (NYSE: USNA) (the "Company," "USANA"), today announced its acquisition of a 78.8% controlling ownership stake in Hiya Health Products, LLC ("Hiya"), a leading direct-to-consumer provider of high-quality children's health & wellness products. The $205 million cash transaction closed on December 23, 2024 and is anticipated to be accretive to USANA's 2025 adjusted EBITDA. For the last twelve months ended September 30, 2024 (unaudited), Hiya generated net sales of $103 million, net income of $19 million, and adjusted EBITDA of $22 million. As of September 30, 2024, Hiya had more than 200,000 customers.
鹽湖城--(美國商業資訊)--USANA Health Sciences, Inc.(紐約證券交易所代碼:USNA)(「公司」,「USANA」)今天宣佈收購領先的高品質兒童健康與保健產品供應商Hiya Health Products, LLC(「Hiya」)78.8%的控股權。這筆2.05億美元的現金交易於2024年12月23日完成,預計將增加USANA2025年調整後的息稅折舊攤銷前利潤。在截至2024年9月30日的最後十二個月中(未經審計),Hiya的淨銷售額爲1.03億美元,淨收入爲1,900萬美元,調整後的息稅折舊攤銷前利潤爲2,200萬美元。截至 2024 年 9 月 30 日,Hiya 擁有超過 200,000 名客戶。
"The Hiya brand is a natural fit for USANA and this acquisition represents a key strategic milestone for our business," said Jim Brown, President and Chief Executive Officer of USANA Health Sciences, Inc. "Hiya's co-founders, Darren Litt and Adam Gillman, have disrupted the children's health and wellness market by building a high quality, better-for-you brand that aligns with our vision of creating the healthiest family on Earth. This strategic acquisition adds a diversified layer of growth to USANA's overall business, while maintaining our commitment to our core direct sales business, where we continue to invest in initiatives to drive growth. Notably, this acquisition will allow USANA to reach a broader audience by diversifying distribution channels through Hiya, which we believe will enhance our ability to generate sustainable long-term growth and deliver value for our stakeholders. Darren and Adam will continue to lead Hiya through its next phase of growth. Their leadership and expertise is instrumental to Hiya's business, which is now part of USANA's mission and strategic objectives."
USANA健康科學公司總裁兼首席執行官吉姆·布朗說:「Hiya品牌天生適合USANA,此次收購是我們業務的關鍵戰略里程碑,」 USANA健康科學公司總裁兼首席執行官吉姆·布朗說,「Hiya的聯合創始人達倫·利特和亞當·吉爾曼通過建立一個高質量、更適合您的品牌,顛覆了兒童健康和保健市場,該品牌符合我們創建地球上最健康家庭的願景。此次戰略收購爲USANA的整體業務增加了多元化的增長層,同時維持了我們對核心直銷業務的承諾,我們將繼續投資於推動增長的舉措。值得注意的是,此次收購將使USANA能夠通過Hiya實現分銷渠道的多元化,從而吸引更廣泛的受衆,我們相信這將增強我們實現可持續長期增長併爲利益相關者創造價值的能力。達倫和亞當將繼續帶領Hiya進入下一階段的增長。他們的領導能力和專業知識對Hiya的業務至關重要,而Hiya的業務現已成爲USANA使命和戰略目標的一部分。」
Darren Litt, co-founder and CEO of Hiya, commented, "Today represents an exciting chapter for Hiya and we are thrilled to join the USANA family. As parents ourselves, we recognized that so many wellness companies did not prioritize our children's health interests, so we created Hiya to give families the very best in clean, honest nutrition. With the help of USANA's extensive capabilities, support and international expertise, we can now extend that commitment to create healthy products for more families in more countries. USANA and Hiya share a deep commitment to improving the lives of families everywhere by providing the best nutritional products possible, and we look forward to continuing this exciting journey as part of USANA."
Hiya聯合創始人兼首席執行官達倫·利特評論說:「今天對Hiya來說是一個激動人心的篇章,我們很高興加入USANA大家庭。作爲父母,我們意識到許多健康公司並未優先考慮孩子的健康利益,因此我們創立了Hiya,旨在爲家庭提供最好的清潔、誠實的營養。在USANA廣泛的能力、支持和國際專業知識的幫助下,我們現在可以擴大這一承諾,爲更多國家的更多家庭生產健康的產品。USANA和Hiya共同堅定地致力於通過提供最好的營養產品來改善世界各地家庭的生活,我們期待作爲USANA的一部分繼續這一激動人心的旅程。」
Strategic Rationale
戰略理由
Fast-Growing, Emerging Leader in the Children's Health and Wellness Market. The acquisition of Hiya provides the opportunity for USANA to expand its presence in the children's health & wellness market through Hiya. For the last twelve months ended September 30, 2024, Hiya's net sales of $103 million grew 50% as compared to fiscal year 2023. For fiscal year 2025, the Company currently anticipates Hiya's net sales growth to approach 30% year-over-year.
Strengthens USANA's Financial Profile. Hiya offers a compelling subscription model with attractive margins, profitability, and cash flow generation, which is expected to enhance the Company's ability to deliver long-term growth and drive shareholder value. Hiya's domestic profitability diversifies USANA's geographic sales mix and is anticipated to lower the Company's consolidated effective tax rate and create a more tax-efficient structure.
Presents Opportunity to Accelerate Growth and Enhance Profitability by Leveraging Synergies. Over the next several years, USANA and Hiya will work together to take advantage of identified synergies, assets and expertise across both companies to create efficiencies, and to accelerate growth and profitability. For example, there are opportunities for Hiya to leverage USANA's significant manufacturing and international expansion expertise. Similarly, USANA may leverage Hiya's market data insights, marketing expertise, and children-focused products within its direct sales channel.
Channel Expansion into Direct-to-Consumer Wellness Market with a Leading and Proven Brand. Hiya currently holds a leading position in children's Vitamins, Minerals & Supplements brand sales in the United Statesi and has a clear pathway and strong growth strategy to become the #1 children's wellness platform through new product introductions, channel expansion, and geographic expansion. Hiya's commitment to being the most trusted and preferred brand for wellness products in the 0-18 age range is an additive category for the Company and is complimentary to USANA's vision of the healthiest family on Earth.
Expands the Company's United States Operations. The transaction meaningfully expands and diversifies the Company's revenue mix as Hiya's net sales are generated in the United States through their direct-to-consumer subscription model, with plans to enter other sales channels. This will allow USANA to reach a broader audience of health-conscious consumers to grow the enterprise's overall customer base.
快速成長的兒童健康和保健市場的新興領導者。收購Hiya爲USANA提供了通過Hiya擴大其在兒童健康與保健市場的影響力的機會。在截至2024年9月30日的最後十二個月中,Hiya的淨銷售額爲1.03億美元,與2023財年相比增長了50%。該公司目前預計,對於2025財年,Hiya的淨銷售額同比增長將接近30%。
強化USANA的財務狀況。Hiya提供引人注目的訂閱模式,具有誘人的利潤率、盈利能力和現金流產生,預計這將增強公司實現長期增長和推動股東價值的能力。Hiya的國內盈利能力使USANA的地域銷售結構多樣化,預計將降低該公司的合併有效稅率並創造更具稅收效率的結構。
通過利用協同效應爲加速增長和提高盈利能力提供了機會。在未來幾年中,USANA和Hiya將共同努力,利用兩家公司已確定的協同效應、資產和專業知識來提高效率,加速增長和盈利。例如,Hiya有機會利用USANA豐富的製造和國際擴張專業知識。同樣,USANA可能會在其直銷渠道中利用Hiya的市場數據洞察力、營銷專業知識和以兒童爲中心的產品。
憑藉領先和久經考驗的品牌,將渠道擴展到直接面向消費者的健康市場。Hiya目前在美國的兒童維生素、礦物質和補充劑品牌銷售方面處於領先地位,並有明確的路徑和強勁的增長戰略,通過新產品推出、渠道擴展和地域擴張成爲 #1 兒童健康平台。Hiya致力於成爲0-18歲年齡段健康產品中最值得信賴和首選的品牌,這是公司的附加類別,也符合USANA對地球上最健康家庭的願景。
擴大公司在美國的業務。該交易有意義地擴大了公司的收入結構並使其多樣化,因爲Hiya的淨銷售額是通過其直接面向消費者的訂閱模式在美國產生的,並計劃進入其他銷售渠道。這將使USANA能夠吸引更廣泛的注重健康的消費者,以擴大企業的整體客戶群。
i Source: Nielsen
i 來源:尼爾森
Transaction Highlights
交易亮點
The Company made an initial cash investment of approximately $205 million (subject to customary closing and post-closing purchase price adjustments) in exchange for a 78.8% ownership stake in Hiya.
Transaction structure includes a put/call feature that provides for USANA's acquisition of the remaining rollover equity at a pre-negotiated valuation scale, which is based on Hiya's financial performance.
The transaction was financed with $200 million cash on hand with the balance covered by the Company's existing credit facility.
該公司進行了約2.05億美元的初始現金投資(視慣例成交和收盤後的收購價格調整而定),以換取Hiya78.8%的所有權。
交易結構包括看跌/看漲期權功能,規定USANA根據Hiya的財務業績,按照預先商定的估值規模收購剩餘的展期股權。
該交易由2億美元的手頭現金融資,餘額由公司現有的信貸額度支付。
BofA Securities acted as exclusive financial advisor to the Company in connection with the transaction. Wilson Sonsini Goodrich & Rosati, P.C. served as the Company's legal advisor. William Hood & Company, LLC acted as exclusive financial advisor to Hiya. Bodman PLC acted as Hiya's legal advisor.
美銀證券擔任該公司與該交易有關的獨家財務顧問。威爾遜·桑西尼·古德里奇和羅薩蒂律師事務所擔任該公司的法律顧問。William Hood & Company, LLC擔任Hiya的獨家財務顧問。Bodman PLC擔任Hiya的法律顧問。
Conference Call
電話會議
The Company will provide a supplemental presentation and discuss the transaction on a conference call on Monday, December 23, 2024 at 5:00 PM Eastern Time. The supplemental presentation and live audio webcast of the conference call will be available on the Company's investor relations website at .
該公司將在美國東部時間2024年12月23日星期一下午 5:00 的電話會議上提供補充演示並討論該交易。電話會議的補充演示和網絡直播將在公司的投資者關係網站上提供,網址爲。
Non-GAAP Financial Measures
非公認會計准則財務指標
This press release contains the non-GAAP financial measure LTM adjusted EBITDA of Hiya. Adjusted EBITDA is a Non-GAAP financial measure of earnings before interest, taxes, depreciation, and amortization that also excludes certain adjustments as indicated below in the reconciliation from net income.
本新聞稿包含Hiya的非公認會計准則財務指標LtM調整後的息稅折舊攤銷前利潤。調整後的息稅折舊攤銷前利潤是衡量未計利息、稅項、折舊和攤銷前收益的非公認會計准則財務指標,其中還不包括淨收益對賬中如下文所示的某些調整。
The Company prepares its financial statements using U.S. generally accepted accounting principles ("GAAP") and investors should not directly compare with or infer relationship from any of the Company's operating results presented in accordance with GAAP to the LTM adjusted EBITDA of Hiya. We believe that this non-GAAP financial information of Hiya may be helpful to investors as an indication of future cash flow generation. Non-GAAP financial measures have limitations in their usefulness to investors because they have no standardized meaning prescribed by GAAP and are not prepared under any comprehensive set of accounting rules or principles. In addition, other companies, including companies in our industry, may calculate similarly titled non-GAAP financial measures differently or may use other measures to evaluate their performance, all of which could reduce the usefulness of non-GAAP financial information as a tool for comparison. As a result, the non-GAAP financial information of Hiya is presented for supplemental informational purposes only and should not be considered in isolation from, or as a substitute for financial information presented in accordance with GAAP.
公司使用美國公認會計原則(「GAAP」)編制財務報表,投資者不應直接將公司根據公認會計原則列報的任何經營業績與Hiya的LtM調整後息稅折舊攤銷前利潤進行比較或推斷其關係。我們認爲,Hiya的這些非公認會計准則財務信息可能會對投資者有所幫助,以此作爲未來現金流產生的指標。非公認會計准則財務指標對投資者的用處有侷限性,因爲它們沒有公認會計原則規定的標準化含義,也不是根據任何全面的會計規則或原則編制的。此外,其他公司,包括我們行業中的公司,可能會以不同的方式計算標題相似的非公認會計准則財務指標,或者可能使用其他衡量標準來評估其業績,所有這些都可能降低非公認會計准則財務信息作爲比較工具的用處。因此,Hiya的非公認會計准則財務信息僅供補充信息之用,不應與根據公認會計原則提供的財務信息分開考慮,也不能作爲其替代品。
The following is a reconciliation of net income, presented and reported in accordance with GAAP, to Adjusted EBITDA:
以下是根據公認會計原則列報和報告的淨收入與調整後息稅折舊攤銷前利潤的對賬情況:
(Unaudited) | |||
Last Twelve Months Ended ($000's) |
|||
30-Sep-24 |
|||
Net income |
$ |
19,416 |
|
Definitional Adjustments: |
|||
Interest expense |
143 |
||
Depreciation and amortization |
38 |
||
Income tax expense |
80 |
||
EBITDA before Adjustments |
19,677 |
||
Adjustments to EBITDA: |
|||
Transaction expenses and other non-recurring items |
760 |
||
Non-operational costs |
566 |
||
Normalizations |
321 |
||
Timing adjustments |
212 |
||
Management compensation |
142 |
||
Adjusted EBITDA |
$ |
21,678 |
(未經審計) | |||
最近十二個月已結束(000美元) |
|||
9 月 30 日至 24 日 |
|||
淨收入 |
$ |
19,416 |
|
定義調整: |
|||
利息支出 |
143 |
||
折舊和攤銷 |
38 |
||
所得稅支出 |
80 |
||
調整前的息稅折舊攤銷前利潤 |
19,677 |
||
息稅折舊攤銷前利潤調整: |
|||
交易費用和其他非經常性項目 |
760 |
||
非運營成本 |
566 |
||
正常化 |
321 |
||
時機調整 |
212 |
||
管理層薪酬 |
142 |
||
調整後 EBITDA |
$ |
21,678 |
About USANA
關於 USANA
USANA develops and manufactures high-quality nutritional supplements, functional foods and personal care products that are sold directly to Associates and Preferred Customers throughout the United States, Canada, Australia, New Zealand, China, Japan, South Korea, Singapore, Mexico, Malaysia, the Philippines, the Netherlands, the United Kingdom, Thailand, France, Belgium, Colombia, Indonesia, Germany, Spain, Romania, Italy, and India. More information on USANA can be found at .
USANA開發和製造高質量的營養補充劑、功能性食品和個人護理產品,直接銷售給美國、加拿大、澳大利亞、新西蘭、中國、日本、韓國、新加坡、墨西哥、馬來西亞、菲律賓、荷蘭、英國、泰國、法國、比利時、哥倫比亞、印度尼西亞、德國、西班牙、羅馬尼亞、意大利和印度的員工和優先客戶。有關USANA的更多信息,請訪問。
About Hiya
關於 Hiya
Hiya is the leading children's health brand, re-imagining kids' wellness with an inspired range of clean-label products. Offering a delicious and high-quality line of powders and chewables, Hiya is at the forefront of wellness with a focused assortment of better-for-you products. Since its founding in 2020, Hiya has established itself as a trusted name in the industry and is loved by both parents and children with adherence to the highest clean nutrition standards, ingredient transparency, and commitment to continuous improvement through ongoing collaborations with experts. More information on Hiya can be found at .
Hiya是領先的兒童健康品牌,通過一系列富有靈感的清潔標籤產品重新構想孩子的健康。Hiya 提供一系列美味高品質的粉末和咀嚼片,站在健康的最前沿,提供種類齊全的更適合您的產品。自2020年成立以來,Hiya已確立了自己作爲業內值得信賴的品牌的地位,並堅持最高的清潔營養標準,成分透明,並致力於通過與專家的持續合作進行持續改進,深受父母和孩子的喜愛。有關Hiya的更多信息,請訪問。
Safe Harbor
安全港
This press release contains forward-looking statements within the meaning of Section 27A of the Securities Act and Section 21E of the Securities Exchange Act, including but not limited to statements that: Hiya is fast growing; the Hiya acquisition will be accretive to USANA's 2025 adjusted EBITDA, experience net sales growth approaching 30% year-over-year in fiscal 2025, allow USANA to reach a broader audience, generate long-term growth, deliver value for USANA stakeholders, scale the Hiya brand, bring better health to children across the country and the world, enhance USANA's geographic sales mix and income tax efficiency in the near and long-term, take advantage of synergies, create efficiencies, accelerate growth and profitability, expand and diversify USANA's revenue mix, grow overall customer base, and strengthen USANA's overall financial profile; Mr. Litt and Mr. Gillman will continue to lead Hiya through its next phase of growth; Hiya will have a clear pathway and growth strategy to become the #1 children's wellness platform through new product introductions, channel expansion, and geographic expansion; and other forward-looking statements. These forward-looking statements are based on current plans, expectations, estimates, forecasts, and projections as well as the beliefs and assumptions of management. Words such as "expect," "vision," "envision," "evolving," "drive," "anticipate," "intend," "maintain," "should," "believe," "continue," "plan," "goal," "opportunity," "estimate," "predict," "may," "will," "could," and "would," and variations of these terms or the negative of these terms and similar expressions are intended to identify these forward-looking statements. Our actual results could differ materially from those projected in these forward-looking statements, which involve a number of risks and uncertainties, many of which involve factors or circumstances that are beyond our control, including: risks that the acquisition disrupts each company's current plans and operations; the diversion of the attention of the management teams of USANA and Hiya from ongoing business operations; the ability of to retain key personnel of Hiya; the ability to realize the benefits of the acquisition, including efficiencies and cost synergies; the ability to successfully integrate Hiya's business with USANA's business, at all or in a timely manner; the amount of the costs, fees, expenses and charges related to the acquisition; global economic conditions generally, including continued inflationary pressure around the world and negative impact on our operating costs, consumer demand and consumer behavior in general; reliance upon our network of independent Associates; risk that our Associate compensation plan, or changes that we make to the compensation plan, will not produce desired results, benefit our business or, in some cases, could harm our business; risk associated with governmental regulation of our products, manufacturing and direct selling business model in the United States, China and other key markets; potential negative effects of deteriorating foreign and/or trade relations between or among the United States, China and other key markets; potential negative effects from geopolitical relations and conflicts around the world, including the Russia-Ukraine conflict and the conflict in Israel; compliance with data privacy and security laws and regulations in our markets around the world; potential negative effects of material breaches of our information technology systems to the extent we experience a material breach; material failures of our information technology systems; adverse publicity risks globally; risks associated with commencing operations in India and future international expansion and operations; uncertainty relating to the fluctuation in U.S. and other international currencies; and the potential for a resurgence of COVID-19, or another pandemic, in any of our markets in the future and any related impact on consumer health, domestic and world economies, including any negative impact on discretionary spending, consumer demand, and consumer behavior in general. The contents of this release should be considered in conjunction with the risk factors, warnings, and cautionary statements that are contained in our most recent filings with the Securities and Exchange Commission. The forward-looking statements in this press release set forth our beliefs as of the date hereof. We do not undertake any obligation to update any forward-looking statement after the date hereof or to conform such statements to actual results or changes in the Company's expectations, except as required by law.
本新聞稿包含《證券法》第27A條和《證券交易法》第21E條所指的前瞻性陳述,包括但不限於以下陳述:Hiya正在快速增長;Hiya的收購將增加USANA2025年調整後的息稅折舊攤銷前利潤,2025財年淨銷售額同比增長接近30%,使USANA能夠吸引更廣泛的受衆,實現長期增長,爲USANA利益相關者創造價值,擴大規模 Hiya品牌,爲全國乃至全世界的兒童帶來更好的健康,在短期和長期內提高USANA的地域銷售組合和所得稅效率,利用協同效應,創造效率,加速增長和盈利能力,擴大和分散USANA的收入組合,擴大整體客戶群,加強USANA的整體財務狀況;利特先生和吉爾曼先生將繼續帶領Hiya進入下一階段的增長;Hiya將制定明確的路徑和增長戰略,通過新產品推出成爲 #1 兒童健康平台、渠道擴張和地域擴張;及其他前瞻性陳述。這些前瞻性陳述基於當前的計劃、預期、估計、預測和預測以及管理層的信念和假設。諸如 「期望」、「願景」、「設想」、「發展」、「驅動」、「預測」、「打算」、「維持」、「應該」、「相信」、「繼續」、「計劃」、「目標」、「機會」、「估計」、「預測」、「可能」 和 「將」 之類的詞語,以及這些術語的變體或其否定之處術語和類似表述旨在識別這些前瞻性陳述。我們的實際業績可能與這些前瞻性陳述中的預測存在重大差異,其中涉及許多風險和不確定性,其中許多涉及我們無法控制的因素或情況,包括:收購干擾各公司當前計劃和運營的風險;USANA和Hiya管理團隊將注意力從正在進行的業務運營上轉移開;留住Hiya關鍵人員的能力;實現收購收益的能力,包括效率和成本協同效應;將Hiya的業務完全或及時地成功整合到USANA業務中的能力;與收購相關的成本、費用、支出和收費金額;總體全球經濟狀況,包括全球持續的通貨膨脹壓力以及對我們運營成本、消費者需求和總體消費者行爲的負面影響;對我們的獨立員工網絡的依賴;我們的員工薪酬計劃或我們對薪酬計劃進行修改的風險,不會產生預期的結果,使我們的業務受益,或者在某些情況下可能損害我們的業務;與美國、中國和其他主要市場的政府對我們的產品、製造和直銷業務模式的監管相關的風險;美國、中國和其他主要市場之間或相互之間外交和/或貿易關係惡化的潛在負面影響;世界各地地緣政治關係和衝突,包括俄羅斯-烏克蘭衝突和以色列衝突的潛在負面影響;遵守數據隱私和安全法律以及我們在全球市場的監管;我們的信息技術系統遭遇重大漏洞的潛在負面影響;我們的信息技術系統出現重大故障;全球負面宣傳風險;與在印度開始運營以及未來國際擴張和運營相關的風險;與美國和其他國際貨幣波動相關的不確定性;以及未來任何市場可能出現的 COVID-19 或其他疫情捲土重來對消費者健康、國內和世界經濟的相關影響,包括對全權支出、消費者需求和一般消費者行爲的任何負面影響。本新聞稿的內容應與我們最近向美國證券交易委員會提交的文件中包含的風險因素、警告和警示聲明一起考慮。本新聞稿中的前瞻性陳述闡述了我們截至發佈之日的信念。除非法律要求,否則我們沒有義務在本聲明發佈之日之後更新任何前瞻性陳述,也沒有義務使此類陳述符合實際業績或公司預期的變化。
View source version on businesswire.com:
在 businesswire.com 上查看源版本:
Investor contact:
Andrew Masuda
Investor Relations
(801) 954-7201
investor.relations@usanainc.com
投資者聯繫方式:
安德魯增田
投資者關係
(801) 954-7201
investor.relations@usanainc.com
Media contact:
Sarah Searle
(801) 954-7626
media@usanainc.com
媒體聯繫人:
莎拉·塞爾
(801) 954-7626
media@usanainc.com
Source: USANA Health Sciences, Inc.
資料來源:USANA 健康科學公司
Released December 23, 2024
2024 年 12 月 23 日發佈
譯文內容由第三人軟體翻譯。